(70 days)
Not Found
No
The summary describes a mechanical implant for spinal fusion and does not mention any software, image processing, or AI/ML terms.
Yes
The CAYMAN LP Plate System is intended for use in spinal fusion procedures to maintain the relative position of weak bony tissue and provide stabilization, which aligns with the definition of a therapeutic device.
No
The device is a spinal implant used to stabilize weak bony tissue during spinal fusion procedures, not to diagnose medical conditions.
No
The device description explicitly states it consists of a plate and screw, which are physical hardware components, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description: The CAYMAN LP Plate System is a physical implantable device (plate and screws) used in spinal fusion surgery. It is designed to maintain the position of bone grafts and prevent cage movement.
- Intended Use: The intended use is for surgical procedures within the body, not for analyzing samples outside the body.
The provided information clearly describes a surgical implant, not a diagnostic test performed on biological samples.
N/A
Intended Use / Indications for Use
The CAYMAN LP Plate System is intended for use in spinal fusion procedures as a means to maintain the relative position of weak bony tissue such as allografts. The device is not intended for load bearing indications.
Product codes (comma separated list FDA assigned to the subject device)
KWQ
Device Description
The CAYMAN LP Plate System are non-load bearing devices, each consisting of a plate and screw for attachment to the vertebral body. The plates are designed to be used as additions to spinal fusion procedures from the lateral and anterior approaches, forming a preventative barrier to intervertebral cage movement.
Materials: The devices are manufactured from Ti6Al4V per ASTM and ISO standards.
Function: The plates are designed to be used in a spinal fusion procedures to provide stabilization and buttressing of tissue in the intervertebral space.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Spinal, intervertebral space
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Nonclinical testing was performed to demonstrate that the CAYMAN LP Plate System is substantially equivalent to its predicate devices. Mechanical tests were performed to test the ability of the plates to resist migration or expulsion of the graft material.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K2M CAYMAN Buttress Plate System (K080302), Innovasis Kestral Buttress Plate System (K181063), Stryker LITe Plate System (K142699)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3060 Spinal intervertebral body fixation orthosis.
(a)
Identification. A spinal intervertebral body fixation orthosis is a device intended to be implanted made of titanium. It consists of various vertebral plates that are punched into each of a series of vertebral bodies. An eye-type screw is inserted in a hole in the center of each of the plates. A braided cable is threaded through each eye-type screw. The cable is tightened with a tension device and it is fastened or crimped at each eye-type screw. The device is used to apply force to a series of vertebrae to correct “sway back,” scoliosis (lateral curvature of the spine), or other conditions.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
May 15, 2019
K2m, Inc. Mr. Casey Hinckley Regulatory Affairs Specialist 600 Hope Parkway, SE Leesburg, Virginia 20175
Re: K190584
Trade/Device Name: CAYMAN LP Plate System Regulation Number: 21 CFR 888.3060 Regulation Name: Spinal intervertebral body fixation orthosis Regulatory Class: Class II Product Code: KWQ Dated: March 5, 2019 Received: March 6, 2019
Dear Mr. Hinckley:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
1
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.htm); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for CAPT Raquel Peat, PhD, MPH, USPHS Director Office of Health Technology 6 Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K190584
Device Name CAYMAN LP Plate System
Indications for Use (Describe)
The CAYMAN LP Plate System is intended for use in spinal fusion procedures as a means to maintain the relative position of weak bony tissue such as allografts. The device is not intended for load bearing indications.
Type of Use (Select one or both, as applicable)
| Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
stryker
2 510(k) Summary
| 510(k) Summary: CAYMAN LP Plate System | |
|---|---|
| Submitter: | K2M, Inc. |
| Contact Person : | Casey Hinckley |
| Regulatory Affairs Specialist | |
| Phone: +1 (571) 919-2318 | |
| Fax: +1 (866) 466-6109 | |
| Email: casey.hinckley@stryker.com | |
| Date Prepared: | March 5, 2019 |
| Trade Name: | CAYMAN LP Plate System |
| Common Name: | Appliance, fixation, spinal intervertebral body |
| Proposed Class: | Class II |
| Classification Name: | Spinal Intervertebral Body Fixation Orthosis (21 CFR 888.3060) |
| Product Code: | KWQ |
| Predicate Devices: | Primary Predicate: K2M CAYMAN Buttress Plate System (K080302) |
Additional Predicates: Innovasis Kestral Buttress Plate System (K181063),
and Stryker LITe Plate System (K142699) |
| Device Description: | The CAYMAN LP Plate System are non-load bearing devices, each consisting
of a plate and screw for attachment to the vertebral body. The plates are
designed to be used as additions to spinal fusion procedures from the lateral
and anterior approaches, forming a preventative barrier to intervertebral
cage movement.
Materials: The devices are manufactured from Ti6Al4V per ASTM and ISO
standards.
Function: The plates are designed to be used in a spinal fusion procedures to
provide stabilization and buttressing of tissue in the intervertebral space. |
| Intended Use: | The CAYMAN LP Plate System is intended for use in spinal fusion procedures
as a means to maintain the relative position of weak bony tissue such as
allografts or autografts. The device is not intended for load bearing
indications. |
| 510(k) Summary: CAYMAN LP Plate System | |
| Summary of the
Technological
Characteristics | The CAYMAN LP Plate System is considered substantially equivalent to other
legally marketed devices. They are similar in design, material, and
indications for use. |
| Summary of the
Performance Data | Nonclinical testing was performed to demonstrate that the CAYMAN LP Plate
System is substantially equivalent to its predicate devices.
Mechanical tests were performed to test the ability of the plates to resist
migration or expulsion of the graft material. |
| Conclusion | The CAYMAN LP Plate System has identical indication, technological
characteristics, and principles of operation as its predicates. The nonclinical
test results demonstrated that the new CAYMAN LP plate is mechanically
superior to the legacy CAYMAN Buttress Plate. The CAYMAN LP Plate
System was shown to be substantially equivalent to its predicate devices. |
4
K190584 - Page 2 of 2
Image /page/4/Picture/1 description: The image shows the word "stryker" in a bold, sans-serif font. The word is in all lowercase letters and is black. There is a horizontal line below the word.